New Suggestion For Men Suffering From Prostate Cancer
May 11 2018
Back in 2012, the USPSTF (the United States Preventative Services Task Force), an independent group of disease prevention, and scientific medicine experts sponsored by the federal government, said, PSA screening for prostate cancer is causing more damage than good.
The PSA test is a simple blood test that attempts to identify men at risk of prostate cancer, but false-positive results can lead to over-diagnosis and unwanted side effects like incontinence and erectile dysfunction.
According to the new guidelines, men ages 70 and older should not be screened.
Attributed to medical and health sector, Melissa very well knows and understands genes, tissues, antidotes, and many other terminologies. We urge those men to talk with their doctors about whether prostate cancer testing is right for them.
After the USPSTF released its findings, the American Urological Association issued an immediate response agreeing with the recommendation. There is also new information on active surveillance-a way of monitoring prostate cancer that may allow some men with low-risk prostate cancers to delay or, in some cases avoid, treatment with radiation or surgery. These specific patients should speak with their clinicians about whether prostate cancer testing is appropriate for them.
A key question is whether the patient has a higher-than-average risk for developing prostate cancer, says Dr. Michael Munger, president of the American Academy of Family Physicians.
A man's lifetime risk of being diagnosed with prostate cancer is about 13 percent, but the lifetime risk of dying of prostate cancer is only 2.5 percent, with half of those deaths occurring at age 80 or beyond, the Task Force authors note in their recommendation statement published on Tuesday in JAMA. "Men should discuss the benefits and harms of screening with their doctor, so they can make the best choice for themselves based on their values and individual circumstances".
USPSTF, Vice Chairman, Dr. Krist, Prof.at Virginia Commonwealth University, Family medicine, and Population Health, said, "The prolonged follow up of 10+ years in this research, which was not handy in 2012, had a huge contribution in the decision of making the changes in the guidelines of screening".